Key result
SCS mutations in the acetylcholine receptor were associated with enhanced recovery from desensitization and slower macroscopic decay currents compared to wild type, correlating with disease severity.
In slow-channel syndrome, recovery from desensitization and slow postsynaptic currents correlate with disease severity, providing mechanistic insight into the genotype-phenotype relationship.
Answers are grounded in this paper and cite their sources.
Should not alter clinical practice in slow-channel syndrome; leaves open mechanistic links to human genotype-phenotype severity.
The slow-channel syndrome (SCS) is a neuromuscular disorder characterized by fatigability, progressive weakness, and degeneration of the neuromuscular junction. The SCS is caused by missense mutations in the four subunits of the skeletal muscle acetylcholine receptor (AChR), which leads to altered channel gating, prolonged neuromuscular postsynaptic currents, and impaired neuromuscular transmission. Although a diverse set of mutations in different functional domains of the AChR appear to be associated with symptoms of widely ranging severity, there is as yet no mutant channel property or combination that explains the variations in disease severity. By observing the recovery time of AChR from desensitization, the authors determined that this process is significantly enhanced in SCS channels. In addition, as expected, the authors found that SCS macroscopic decay currents in transfected HEK293 cells are slower than wild type currents. While slight differences in relative Ca(2+) permeability between some SCS mutations were identified, they did not correlate with apparent disease severity. These results suggest that of the different AChR kinetic features studied, only recovery from desensitization and slow postsynaptic currents correlate with the severity observed in the different mutations of this syndrome.
No takes yet. Share an insight, caveat, or question.
Zayas et al. (2006) studied Slow-channel syndrome. SCS mutations in acetylcholine receptor vs. Wild type was evaluated on Recovery time from desensitization and macroscopic decay currents. SCS mutations in the acetylcholine receptor were associated with enhanced recovery from desensitization and slower macroscopic decay currents compared to wild type, correlating with disease severity.
Synapse has enriched 10 related papers. Consider them for comparative context: